Catherine DeVoe

588 total citations
13 papers, 275 citations indexed

About

Catherine DeVoe is a scholar working on Infectious Diseases, Oncology and Epidemiology. According to data from OpenAlex, Catherine DeVoe has authored 13 papers receiving a total of 275 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 5 papers in Oncology and 4 papers in Epidemiology. Recurrent topics in Catherine DeVoe's work include Neutropenia and Cancer Infections (4 papers), Antifungal resistance and susceptibility (3 papers) and COVID-19 Clinical Research Studies (3 papers). Catherine DeVoe is often cited by papers focused on Neutropenia and Cancer Infections (4 papers), Antifungal resistance and susceptibility (3 papers) and COVID-19 Clinical Research Studies (3 papers). Catherine DeVoe collaborates with scholars based in United States and France. Catherine DeVoe's co-authors include John E. Conte, Jeffrey A. Golden, Emily Little, Monica Fung, Deborah S. Yokoe, Jennifer M. Babik, Peter Chin‐Hong, Sindhu Chandran, Steven R. Hays and Timothy J. Henrich and has published in prestigious journals such as Gastroenterology, Clinical Cancer Research and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Catherine DeVoe

12 papers receiving 271 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Catherine DeVoe United States	7	175	89	75	38	37	13	275
Mahesh Shah Nepal	10	222 1.3×	95 1.1×	19 0.3×	12 0.3×	18 0.5×	32	354
Brianna M. Doratt United States	11	97 0.6×	52 0.6×	11 0.1×	49 1.3×	22 0.6×	22	273
Khaled Albakri Jordan	8	41 0.2×	70 0.8×	12 0.2×	16 0.4×	14 0.4×	42	245
Anne Bignon France	6	110 0.6×	86 1.0×	55 0.7×	2 0.1×	4 0.1×	10	212
Xin Tan China	6	141 0.8×	25 0.3×	28 0.4×	45 1.2×	41 1.1×	19	224
Laura Cursi Italy	8	52 0.3×	50 0.6×	15 0.2×	6 0.2×	11 0.3×	21	181
Xixian Zhao China	4	213 1.2×	34 0.4×	35 0.5×	9 0.2×	132 3.6×	5	402
Kazuhiko Ikeuchi Japan	10	142 0.8×	129 1.4×	62 0.8×	3 0.1×	25 0.7×	40	368
Theologia Gkavogianni Greece	8	132 0.8×	66 0.7×	8 0.1×	64 1.7×	14 0.4×	15	382
Sajjad Biglari Iran	3	127 0.7×	15 0.2×	17 0.2×	17 0.4×	30 0.8×	16	222

Countries citing papers authored by Catherine DeVoe

Since Specialization

Citations

This map shows the geographic impact of Catherine DeVoe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine DeVoe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine DeVoe more than expected).

Fields of papers citing papers by Catherine DeVoe

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine DeVoe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine DeVoe. The network helps show where Catherine DeVoe may publish in the future.

Co-authorship network of co-authors of Catherine DeVoe

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine DeVoe. A scholar is included among the top collaborators of Catherine DeVoe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine DeVoe. Catherine DeVoe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Fung, Monica, Nimish Patel, Catherine DeVoe, et al.. (2024). Utility of Serial Microbial Cell-free DNA Sequencing for Inpatient and Outpatient Pathogen Surveillance Among Allogeneic Hematopoietic Stem Cell Transplant Recipients. Open Forum Infectious Diseases. 11(8). ofae330–ofae330. 2 indexed citations

DeVoe, Catherine, Shagun Arora, Timothy J. Henrich, et al.. (2022). COVID‐19 in vaccinated versus unvaccinated hematologic malignancy patients. Transplant Infectious Disease. 24(6). e13835–e13835. 4 indexed citations

Fung, Monica, Catherine DeVoe, Natasha Spottiswoode, & Sarah B. Doernberg. (2022). Maribavir for Cytomegalovirus Treatment in the Real World—Not a Silver Bullet. Open Forum Infectious Diseases. 10(1). ofac686–ofac686. 9 indexed citations

DeVoe, Catherine, Mark R. Segal, Lusha Wang, et al.. (2021). Increased rates of secondary bacterial infections, including Enterococcus bacteremia, in patients hospitalized with coronavirus disease 2019 (COVID-19). Infection Control and Hospital Epidemiology. 43(10). 1416–1423. 34 indexed citations

Trinh, Trang D, Luke Strnad, Lloyd E. Damon, et al.. (2021). Reductions in vancomycin and meropenem following the implementation of a febrile neutropenia management algorithm in hospitalized adults: An interrupted time series analysis. Infection Control and Hospital Epidemiology. 42(9). 1090–1097. 4 indexed citations

Fung, Monica, Charles Y. Chiu, Catherine DeVoe, et al.. (2020). Clinical outcomes and serologic response in solid organ transplant recipients with COVID-19: A case series from the United States. American Journal of Transplantation. 20(11). 3225–3233. 54 indexed citations

Fung, Monica, Ashok Nambiar, Suchitra Pandey, et al.. (2020). Treatment of immunocompromised COVID‐19 patients with convalescent plasma. Transplant Infectious Disease. 23(2). e13477–e13477. 39 indexed citations

DeVoe, Catherine, et al.. (2019). 2685. Oral Third-Generation Cephalosporins vs. Levofloxacin for Antibacterial Prophylaxis in Neutropenic Patients with Hematologic Malignancies. Open Forum Infectious Diseases. 6(Supplement_2). S943–S943.

DeVoe, Catherine, Monica Fung, Brian S. Schwartz, et al.. (2018). 415. Breakthrough Invasive Fungal Infections in Adult Hematologic Malignancy Patients Receiving Isavuconazole Prophylaxis. Open Forum Infectious Diseases. 5(suppl_1). S158–S159. 2 indexed citations

10.

Lucas, Aimee L., Reena Shakya, Marla Lipsyc, et al.. (2013). High Prevalence of BRCA1 and BRCA2 Germline Mutations with Loss of Heterozygosity in a Series of Resected Pancreatic Adenocarcinoma and Other Neoplastic Lesions. Clinical Cancer Research. 19(13). 3396–3403. 54 indexed citations

11.

Lucas, Aimee L., Reena Shakya, Marla Lipsyc, et al.. (2012). Su1810 Demonstration of a High Frequency of BRCA1 and BRCA2 Germline Mutations With Loss of Heterozygosity: A Series of Resected Pancreatic Adenocarcinomas and Other Preneoplastic Lesions. Gastroenterology. 142(5). S–509. 1 indexed citations

12.

Walsh, Thomas J., Sylvain Goutelle, Jeffrey A. Golden, et al.. (2010). Intrapulmonary Pharmacokinetics and Pharmacodynamics of Micafungin in Adult Lung Transplant Patients. Antimicrobial Agents and Chemotherapy. 54(8). 3451–3459. 36 indexed citations

13.

Conte, John E., Catherine DeVoe, Emily Little, & Jeffrey A. Golden. (2010). Steady-State Intrapulmonary Pharmacokinetics and Pharmacodynamics of Posaconazole in Lung Transplant Recipients. Antimicrobial Agents and Chemotherapy. 54(9). 3609–3613. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact